Mivacurium dichloride
Cat. No.：YN360883
CAS No. ：106861-44-3
| 产品名称: | Mivacurium dichloride |
| CAS No.: | 106861-44-3 |
| Chemical Name: | (1R,1’R)-2,2’-[[(4E)-1,8-dioxo-4-octene-1,8-diyl]bis(oxy-3,1-propanediyl)]bis[1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl] isoquinolinium, dichloride |
| Synonyms: | 米库氯铵,Mivacurium chloride,二氯美维库铵 |
| 分子量: | 1100.17 |
| 分子式: | C₅₈H₈₀Cl₂N₂O₁₄ |
| SMILES: | O=C(OCCC[N+]1(C)[C@H](CC2=CC(OC)=C(OC)C(OC)=C2)C3=C(C=C(OC)C(OC)=C3)CC1)CC/C=C/CCC(OCCC[N+]4(C)[C@H](CC5=CC(OC)=C(OC)C(OC)=C5)C6=C(C=C(OC)C(OC)=C6)CC4)=O.[Cl-].[Cl-] |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Mivacurium dichloride 是一种苄基异喹啉衍生物，也是一种短效非去极化神经肌肉阻滞剂和骨骼肌松弛剂。Mivacurium dichloride 可与nAChR偶联，以减少或抑制乙酰胆碱对肌肉细胞末端盘的去极化作用。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Okanlami, O.A., Fryer, A.D., and Hirshman, C.Interaction of nondepolarizing muscle relaxants with M2 and M3 muscarinic receptors in guinea pig lung and heartAnesthesiology84(1),155-161(1996)
Johnsson, M., Gurley, D., Dabrowski, M., et al.Distinct pharmacologic properties of neuromuscular blocking agents on human neuronal nicotinic acetylcholine receptors: A possible explanation for the train-of-four fadeAnesthesiology105(3),521-533(2006)
Clutton, R.E., and Glasby, M.A.A comparison of the neuromuscular and cardiovascular effects of vecuronium, atracurium and mivacurium in sheepRes. Vet. Sci.64(3),233-237(1998)
Zeng, R., Liu, X., Zhang, J., et al.The efficacy and safety of mivacurium in pediatric patientsBMC Anesthesiol.17(1),58(2017)
